ScholarIQanswers from OpenAlex

An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition

PaperCitations, authors & open-access status

An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition is a paper indexed in ScholarIQ from OpenAlex.

How many citations does An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition have?

ScholarIQcitation count

An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition has 374 citations in the OpenAlex counts ScholarIQ stores.

When was An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition published?

ScholarIQyear

An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition has 2014 year in the ScholarIQ index.

What is the open-access status of An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition?

ScholarIQoa status

An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition has closed oa status in the ScholarIQ index.

What is the DOI of An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition?

ScholarIQdoi

The DOI for An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition is on the source record.

What is the PMID of An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition?

ScholarIQpmid

The PMID for An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition is on the source record.

What is the OpenAlex record for An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition?

ScholarIQopenalex

The OpenAlex for An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial